Department of Medicine

People

  1. Desai
    Desai
  2. Green
    Green
  3. Dickson
    Dickson
  4. Ilson
    Ilson
  5. Gupta
    Gupta
  6. Perales
    Perales
  7. Peled
    Peled
  8. Harris
    Harris
  9. Seidman
    Seidman
  10. Hohl
    Hohl
  11. Connell
    Connell
  12. Robson
    Robson
  13. Ludwig
    Ludwig
  14. Sklarin
    Sklarin
  15. Yu
    Yu

Description

Publications

  1. Journal of Clinical Oncology (6050)
  2. Blood (3570)
  3. Annals of Oncology (1395)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (890)
  6. Biology of Blood and Marrow Transplantation (679)
  7. Journal of Thoracic Oncology (547)
  8. Cancer (538)
  9. International Journal of Radiation Oncology, Biology, Physics (504)
  10. Gynecologic Oncology (445)

Publishers

  1. American Society of Clinical Oncology (6326)
  2. Elsevier Inc. (4609)
  3. American Society of Hematology (3841)
  4. American Association for Cancer Research (2074)
  5. Nature Publishing Group (2015)
  6. Oxford University Press (2002)
  7. Springer (1619)
  8. Wiley Blackwell (1520)
  9. Elsevier Science, Inc. (1334)
  10. Lippincott Williams & Wilkins (1103)

Types of Work

Recent Works

  1. US geriatric assessment practices for older adults undergoing hematopoietic cell transplantation or chimeric antigen receptor T cell therapy: An American Society for Transplantation and Cellular Therapy Physician survey from the Aging Special Interest Group and Committee on Practice Guidelines
    Guidelines

    Munshi, P. N.; Olin, R. L.; Wall, S.; McCurdy, S. R.; Al-Juhaishi, T.; Baker, J.; Bhatt, V. R.; Chokr, N.; Dahi, P.; DeFilipp, Z.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  2. Error-corrected flow-based sequencing at whole-genome scale and its application to circulating cell-free DNA profiling
    Journal Article

    Cheng, A. P.; Widman, A. J.; Arora, A.; Rusinek, I.; Sossin, A.; Rajagopalan, S.; Midler, N.; Hooper, W. F.; Murray, R. M.; Halmos, D.; more...
    Nature Methods (2025)

    Fulltext@MSK | Save
  3. Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: A randomized phase 3 trial
    Journal Article

    Rampal, R. K.; Grosicki, S.; Chraniuk, D.; Abruzzese, E.; Bose, P.; Gerds, A. T.; Vannucchi, A. M.; Palandri, F.; Lee, S. E.; Gupta, V.; more...
    Nature Medicine (2025)

    Fulltext@MSK | Save